Sequencing and Genomic Technologies (SGT) is a basic science research core affiliated with the Duke Cancer Institute (DCI) that offers a full range of state-of-the-art genomic services. For answers to common questions, please visit our Frequently Asked Questions page.

Director Devi Swain Lenz is available for project consultations.

News & Announcements

PacBio Revio Launch Party

The Sequencing and Genomic Technologies Core Facility will host a launch party for the new PacBio Revio long-read sequencer. 


Job Posting: Bioinformatician

The Sequencing and Genomics Technologies (SGT) Core Facility at Duke University is hiring a Bioinformatician! The successful candidate will lead bioinformatic analyses for a broad range of genomics projects. The candidate will consult and collaborate with researchers and scientists from multiple disciplines across Duke’s campus on projects utilizing high-throughput next-generation sequencing and provide quality analyses on high-throughput sequencing data sets. The candidate will also support the SGT to analyze new experimental methods.

Swain Lenz to Speak at Large Genomic Conference

Sequencing and Genomic Technologies Director, Devjanee (Devi) Swain Lenz, will be one of the invited panel speakers at the Festival of Genomics and Biodata conference in Boston on October 4-5.

The Festival is the world’s largest open access genomics event and covers a host of topics. There will be 120 sessions with 150 invited speakers and 100 exhibitors. Swain Lenz will be on a panel discussing “The Resolution Revolution: Going Beyond Single-Cell Analysis As You Know It.”

New Year, New NextSeq

The Sequencing and Genomic Technologies core facility has acquired a new sequencing platform. The llumina NextSeq 1000 produces 100-400 M reads at a variety of read lengths, including 300 bp paired-end reads at a fraction of the price of the NextSeq 500 and MiSeq.

Oxford Nanopore Technology GridION: Putting More Bases in Their Places

The Sequencing and Genomic Technologies (SGT) Core Facility recently added an Oxford Nanopore GridION long-read sequencer to its arsenal. The GridION provides cost-effective, ultra-long sequencing reads of hundreds of kilobases to help answer research questions that short read sequencers cannot.

“Parts of the genome are difficult to sequence because they are very long and repetitive,” associate director of SGT Devi Swain-Lenz said. “GridION provides longer stretches of DNA or RNA sequencing so researchers can get a fuller picture of what is happening in that genetic material.”